Multidisciplinary care in pediatric severe asthma: A comparative outcomes analysis
Background: There are limited data comparing the effectiveness of multidisciplinary severe asthma clinics (SACs) with that of conventional single-discipline clinics (SDCs) for pediatric severe asthma. Objective: Our aim was to compare asthma outcomes between SACs and SDCs clinics and examine longitu...
| Published in: | Journal of Allergy and Clinical Immunology: Global |
|---|---|
| Main Authors: | Adam S. Price, MD, Akilah A. Jefferson-Shah, MD, Robert D. Pesek, MD, Erhan Ararat, MD, Safia F. Nawaz, MD, Matthew Pertzborn, MD, Kim Cobb, RT, Haley Long, RT, Monica Y. Miller, LMSW, Brandi N. Whitaker, PhD, Stacie M. Jones, MD, Scott Stewart, MS, Daniel Liu, MD, Tamara T. Perry, MD |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829325000189 |
Similar Items
Three-dimensional bronchial tree visualization in exercise-induced severe asthma following tezepelumab treatment
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01)
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01)
Factors associated with aeroallergen testing among adults with asthma in a large health system
by: Patrick K. Gleeson, MD, MSCE, et al.
Published: (2023-11-01)
by: Patrick K. Gleeson, MD, MSCE, et al.
Published: (2023-11-01)
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
by: Katherine Caid, MD, et al.
Published: (2024-11-01)
by: Katherine Caid, MD, et al.
Published: (2024-11-01)
Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma
by: Tamo Sultan, MD, et al.
Published: (2024-12-01)
by: Tamo Sultan, MD, et al.
Published: (2024-12-01)
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01)
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01)
Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stability
by: Mana Ishizuka, MD, et al.
Published: (2025-05-01)
by: Mana Ishizuka, MD, et al.
Published: (2025-05-01)
Socioeconomic status, diet, and recurrent severe asthma exacerbations in Puerto Rican youth
by: Kristina Gaietto, MD MPH, et al.
Published: (2024-05-01)
by: Kristina Gaietto, MD MPH, et al.
Published: (2024-05-01)
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
by: Marco Caminati, MD, et al.
Published: (2024-08-01)
by: Marco Caminati, MD, et al.
Published: (2024-08-01)
Prevalence, associated factors, and impact of adolescent asthma in Taiwan: Global Asthma Network phase I survey
by: Kuan-Wen Su, MD, PhD, et al.
Published: (2023-07-01)
by: Kuan-Wen Su, MD, PhD, et al.
Published: (2023-07-01)
Disparities in adult asthma outcomes among disaggregated data among Asian Americans in the National Health Interview Survey
by: Alan Zhang, BS, et al.
Published: (2025-08-01)
by: Alan Zhang, BS, et al.
Published: (2025-08-01)
Uncontrolled asthma in school-aged children—a nationwide specialist care study
by: Caroline Stridsman, PhD, et al.
Published: (2024-05-01)
by: Caroline Stridsman, PhD, et al.
Published: (2024-05-01)
Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series
by: Shigesato Inoue, MD, et al.
Published: (2025-05-01)
by: Shigesato Inoue, MD, et al.
Published: (2025-05-01)
Home exposure to moisture and mold is associated with poorer asthma control in children: CHAMPIASTHMA study
by: Margaux Sauvere, MD, et al.
Published: (2025-05-01)
by: Margaux Sauvere, MD, et al.
Published: (2025-05-01)
Moving to lower-poverty neighborhoods offers broad benefits for children with asthma, regardless of sex or other baseline characteristics
by: Torie L. Grant, MD, MHS, et al.
Published: (2025-05-01)
by: Torie L. Grant, MD, MHS, et al.
Published: (2025-05-01)
Clinical features in patients with COVID-19 treated with biologics for severe asthma
by: Takanori Numata, MD, PhD, et al.
Published: (2024-05-01)
by: Takanori Numata, MD, PhD, et al.
Published: (2024-05-01)
ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025
by: Carlo Lombardi, MD, et al.
Published: (2025-05-01)
by: Carlo Lombardi, MD, et al.
Published: (2025-05-01)
Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
by: José Antonio Castillo, MD, PhD, et al.
Published: (2023-11-01)
by: José Antonio Castillo, MD, PhD, et al.
Published: (2023-11-01)
Delays in Referral to Multidisciplinary Care for Black Individuals With SarcoidosisTake-Home Points
by: Kristen R. Mathias, MD, et al.
Published: (2025-06-01)
by: Kristen R. Mathias, MD, et al.
Published: (2025-06-01)
Digital tools in allergy and respiratory care
by: Elisabeth Verhoeven, MD, et al.
Published: (2022-07-01)
by: Elisabeth Verhoeven, MD, et al.
Published: (2022-07-01)
Pediatric asthma comorbidities: Global impact and unmet needs
by: Elham Hossny, MD, PhD, et al.
Published: (2024-05-01)
by: Elham Hossny, MD, PhD, et al.
Published: (2024-05-01)
Predictors of persistent poor control and validation of ASSESS score: Longitudinal 5-year follow-up of severe asthma cohort
by: Pei Yee Tiew, MD, PhD, et al.
Published: (2024-02-01)
by: Pei Yee Tiew, MD, PhD, et al.
Published: (2024-02-01)
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01)
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01)
Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR)
by: Youngsoo Lee, MD, et al.
Published: (2024-05-01)
by: Youngsoo Lee, MD, et al.
Published: (2024-05-01)
Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01)
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01)
Association between orchiectomy and asthma: Insights from 2 population-based cohorts
by: Battoul Fakhry, MD, et al.
Published: (2025-05-01)
by: Battoul Fakhry, MD, et al.
Published: (2025-05-01)
Trends in telemedicine visits among pediatric asthma patients during COVID-19
by: Kaitlin Hall, MD, MPH, MS, et al.
Published: (2024-05-01)
by: Kaitlin Hall, MD, MPH, MS, et al.
Published: (2024-05-01)
Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)
Tezepelumab for asthma with current or previous smoking habit: Case series
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01)
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01)
Direct and Indirect Costs of Asthma in School-age Children
by: Li Yan Wang, MBA, MA, et al.
Published: (2005-01-01)
by: Li Yan Wang, MBA, MA, et al.
Published: (2005-01-01)
Vitamin D3 resolved human and experimental asthma via B lymphocyte–induced maturation protein 1 in T cells and innate lymphoid cells
by: Janina C. Grund, et al.
Published: (2023-08-01)
by: Janina C. Grund, et al.
Published: (2023-08-01)
Validity study of the Japanese version of the Nijmegen Questionnaire for verifying dysfunctional breathing in Japanese asthma patients
by: Shoko Kotera, MD, et al.
Published: (2024-08-01)
by: Shoko Kotera, MD, et al.
Published: (2024-08-01)
AI model for predicting asthma prognosis in children
by: Elham Sagheb, MS, et al.
Published: (2025-05-01)
by: Elham Sagheb, MS, et al.
Published: (2025-05-01)
Depression in children with asthma: Testing a cholinergically mediated “endotype”
by: Heather K. Lehman, MD, FAAAAI, et al.
Published: (2026-01-01)
by: Heather K. Lehman, MD, FAAAAI, et al.
Published: (2026-01-01)
Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015
by: Jung-Hyun Kim, MD, PhD, et al.
Published: (2023-04-01)
by: Jung-Hyun Kim, MD, PhD, et al.
Published: (2023-04-01)
Detection and prediction of real-world severe asthma phenotypes by application of machine learning to electronic health records
by: Mehmet Furkan Bağcı, MSc, et al.
Published: (2025-08-01)
by: Mehmet Furkan Bağcı, MSc, et al.
Published: (2025-08-01)
Association between asthma and cardiovascular diseases: A longitudinal follow-up study using a national health screening cohort
by: Hyo Geun Choi, MD, PhD, et al.
Published: (2024-06-01)
by: Hyo Geun Choi, MD, PhD, et al.
Published: (2024-06-01)
Prospective REALITI-A StudyTake-home Points
by: Cristiano Caruso, MD, PhD, et al.
Published: (2025-03-01)
by: Cristiano Caruso, MD, PhD, et al.
Published: (2025-03-01)
Fractional exhaled nitric oxide distribution and its relevant factors in the general adult population and its healthy subpopulation
by: Mitsuhiro Yamada, MD, PhD, et al.
Published: (2024-08-01)
by: Mitsuhiro Yamada, MD, PhD, et al.
Published: (2024-08-01)
Anti–IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis
by: Pedro A. Lamothe, MD, PhD, et al.
Published: (2025-02-01)
by: Pedro A. Lamothe, MD, PhD, et al.
Published: (2025-02-01)
Benralizumab treatment and 3-dimensional bronchial tree changes in chronic eosinophilic pneumonia
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-08-01)
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-08-01)
Similar Items
-
Three-dimensional bronchial tree visualization in exercise-induced severe asthma following tezepelumab treatment
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01) -
Factors associated with aeroallergen testing among adults with asthma in a large health system
by: Patrick K. Gleeson, MD, MSCE, et al.
Published: (2023-11-01) -
Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
by: Katherine Caid, MD, et al.
Published: (2024-11-01) -
Levels of total IgE versus specific IgE during childhood for defining and predicting T2-high asthma
by: Tamo Sultan, MD, et al.
Published: (2024-12-01) -
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01)
